Antibody discovery and optimization

Discovery Pipeline

MAbSilico applied its solutions to build a discovery pipeline available for partnering and assay development.

Transform weeks into days

Improved research throughput and  turnaround times

400% ROI

Reduced timelines and decreased labor for fewer experimental repeats

6 months

Get your lead candidates ready for preclinical studies

60% cost saving per target

Bridging AI and experimental validations for quicker and more precise drug candidate selection

Theragnostic application

Use MAbSilico solutions for therapeutic and/or diagnostic antibody design

What we have already done

Data mining
Computational design
Biological assessments
Competitive analysis
Preprocessing & Epitope ID
2 weeks
Antibody design
3 weeks
Binding validation
2 to 4 weeks
MoA
4 weeks
In Vivo
In Vivo
10 weeks
Pre-clinic
Infectiology
Oncology /
immuno-oncology
Inflammation
Undisclosed target
SARS-CoV-2
CMV
TIM3
VEGFA
In progress
PD1
VEGFA / PD1
PD1 / TIM3
TSLP
Binding validation
MoA
Binding validation
Binding validation
Binding validation
Binding validation
MoA
Infectiology
SARS-CoV-2
In Vivo
CMV
Binding validation
In progress
Oncology /
immuno-oncology
TIM3
Moa
VEGFA
Binding validation
PD1
Binding validation
VEGFA / PD1
Binding validation
PD1 / TIM3
Binding validation
Inflammation
TSLP
MOA
Undisclosed targets
Set up for new targets

Get in touch !

Drop us a line if you want to know more about our technology or if you are willing to talk about your projects. We are always keen on discussing science!

Contact us